Furthermore, Geng et al reported that ID1 enhances docetaxel cytotoxicity in prostate cancer cells through p21 inhibition and suggested that ID1 is a novel prognostic marker and therapeutic target in prostate cancer chemotherapy (33). The gene discussed is ID1; the disease is Familial prostate cancer.